PDB29 HEALTH ECONOMIC EVALUATION OF INSULIN GLARGINE FOR THE TREATMENT OF TYPE-1 AND TYPE-2 DIABETES
Melissa L. Thompson Bastin+2 more
openalex +1 more source
Glargine insulin: an alternative to regular insulin for glycemic control in critically ill patients [PDF]
Mahuya Bhattacharyya+2 more
openalex +1 more source
Patients with type 2 diabetes inadequately controlled on premixed insulin: effect of initiating insulin glargine plus oral antidiabetic agents on glycaemic control in daily practice* [PDF]
Hilde Berner Hammer, Andreas Klinge
openalex +1 more source
Comment on: Distiller LA, Joffe BI (2006) From the coalface: does glargine insulin improve hypoglycaemic episodes, glycaemic control or affect body mass in type 1 diabetic subjects who are attending a ‘routine’ diabetes clinic? Diabetologia 49:2793–2794 [PDF]
David S.H. Bell
openalex +1 more source
Comment and Reply on:Relative efficacy/effectiveness and relative costs of treatment with insulin glargine and insulin detemir [PDF]
Nick Freemantle+4 more
openalex +1 more source
Nocturnal Glucose Metabolism after Bedtime Injection of Insulin Glargine or Neutral Protamine Hagedorn Insulin in Patients with Type 2 Diabetes [PDF]
Thomas Linn+6 more
openalex +1 more source